Sam Eiber
Stock Analyst at BTIG
(1.80)
# 3,432
Out of 5,157 analysts
14
Total ratings
41.67%
Success rate
-5.66%
Average return
Main Sectors:
Stocks Rated by Sam Eiber
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SBC SBC Medical Group Holdings | Initiates: Buy | $8 | $3.75 | +113.33% | 1 | Mar 6, 2026 | |
| EOLS Evolus | Reiterates: Buy | $13 | $5.28 | +146.21% | 5 | Mar 4, 2026 | |
| ESTA Establishment Labs Holdings | Maintains: Buy | $86 → $88 | $66.35 | +32.63% | 4 | Feb 24, 2026 | |
| MMSI Merit Medical Systems | Initiates: Buy | $107 | $69.71 | +53.49% | 1 | Feb 6, 2026 | |
| INMD InMode | Downgrades: Neutral | n/a | $13.27 | - | 2 | Apr 29, 2025 | |
| APYX Apyx Medical | Initiates: Neutral | n/a | $3.45 | - | 1 | Oct 17, 2024 |
SBC Medical Group Holdings
Mar 6, 2026
Initiates: Buy
Price Target: $8
Current: $3.75
Upside: +113.33%
Evolus
Mar 4, 2026
Reiterates: Buy
Price Target: $13
Current: $5.28
Upside: +146.21%
Establishment Labs Holdings
Feb 24, 2026
Maintains: Buy
Price Target: $86 → $88
Current: $66.35
Upside: +32.63%
Merit Medical Systems
Feb 6, 2026
Initiates: Buy
Price Target: $107
Current: $69.71
Upside: +53.49%
InMode
Apr 29, 2025
Downgrades: Neutral
Price Target: n/a
Current: $13.27
Upside: -
Apyx Medical
Oct 17, 2024
Initiates: Neutral
Price Target: n/a
Current: $3.45
Upside: -